NAT9 anticorps
-
- Antigène Tous les produits NAT9
- NAT9 (N-Acetyltransferase 9 (NAT9))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NAT9 est non-conjugé
-
Application
- Immunofluorescence (IF)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein of human NAT9 (NP_056469.2).
- Isotype
- IgG
-
-
- Indications d'application
- IF 1:50-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- NAT9 (N-Acetyltransferase 9 (NAT9))
- Autre désignation
- NAT9 (NAT9 Produits)
- Synonymes
- anticorps EBSP, hNATL, anticorps 1110028N05Rik, anticorps N-acetyltransferase 9 (putative), anticorps N-acetyltransferase 9 (GCN5-related, putative), anticorps NAT9, anticorps Nat9
- Sujet
- NAT9 (N-Acetyltransferase 9 (Putative)) is a Protein Coding gene. Diseases associated with NAT9 include Lymphogranuloma Venereum and Granuloma Inguinale. Among its related pathways are Cytochrome P450 - arranged by substrate type. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring acyl groups other than amino-acyl groups and N-acetyltransferase activity.
- ID gène
- 26151
- UniProt
- Q9BTE0
-